Results 121 to 130 of about 9,878 (259)
Cryptogenic Organizing Pneumonia: A Series of 25 Cases
Epidemiology International, 2020 Introduction: Cryptogenic Organizing Pneumonia (COP) earlier known as ‘Bronchiolitis Obliterans with Organizing Pneumonia’ (BOOP), is a rare lung condition in which the bronchioles, alveoli and the walls of small bronchi become inflamed and plugged with connective tissue. The condition is called “cryptogenic” because the cause is unknown.
Kavita Upadhyay, Vikas Ratnaparkhe
openaire +3 more sources
Reversed Halo Sign: Presents in Different Pulmonary Diseases. [PDF]
PLoS ONE, 2015 To observe the incidence of reversed halo sign in different pulmonary diseases and the pathological correspondence of reversed halo sign.Retrospectively studied the high resolution computer tomography scans of all the patients who were admitted in our ...
Xi Zhan +5 more
doaj +1 more source
Journal of General and Family Medicine, Volume 26, Issue 4, Page 292-296, July 2025.
Takao Wakabayashi +5 more
wiley +1 more source
Cryptogenic organizing pneumonia due to ortho-phenylenediamine
Respiratory Medicine CME, 2011 AbstractCryptogenic organizing pneumonia (COP) is a rare, potentially serious respiratory disease which may be idiopathic or secondary to other conditions. Exceptionally, cases of COP of occupational origin have been reported. We present the case of a laboratory researcher who developed COP after prolonged exposure to ortho-phenylenediamine.
María Jesús Cruz +4 more
openaire +2 more sources
Case of cryptogenic organizing pneumonia
Consilium Medicum, 2020 Cryptogenic organizing pneumonia is a diffuse lung disease characterized by excessive proliferation of granulomatous tissue in the small bronchi and alveoli and moderate interstitial inflammation. The diagnosis requires a multidisciplinary approach involving a pulmonologist, a radiologist and, in some cases, a mor-phologist.
Yuliya G. Belotserkovskaya +3 more
openaire +1 more source
Pharmacology Research &Perspectives, Volume 13, Issue 2, April 2025.ABSTRACT Interstitial lung disease (ILD) is a clinically relevant adverse event associated with biologic agent use. However, the current incidence of ILD remains unclear as large‐scale risk assessments of biologic agents have not been conducted. The aim of this study was to clarify the association between biologic agent use and ILD development in ...
Ayu Minagi +7 more
wiley +1 more source
The lung in primary immunodeficiencies: new concepts in infection and inflammation [PDF]
, 2018 Immunoglobulin replacement therapy (IGRT) has contributed critically to the management of primary antibody deficiencies (PAD) and the decrease in pneumonia rate.
Baumann, Ulrich +4 more
core +4 more sources
Physiological Reports, Volume 13, Issue 7, April 2025.Abstract We report the case of a 54‐year‐old man with right‐lung pneumonia and contralateral pulmonary embolism (PE) conditioning severe refractory hypoxemia requiring veno‐venous extracorporeal membrane oxygenation. Electrical impedance tomography (EIT) was used to assess recruitability and regional ventilation and perfusion.
Roberta Garberi +6 more
wiley +1 more source
Evaluation of the use of transbronchial biopsy in patients with clinical suspicion of interstitial lung disease [PDF]
, 2011 OBJETIVO: Estudar os padrões clínicos, radiológicos e histopatológicos da biópsia transbrônquica (BTB) utilizados para a confirmação diagnóstica em pacientes com suspeita clinica de doença pulmonar intersticial (DPI) atendidos em um hospital ...
CAPELOZZI, Vera Luiza +6 more
core +4 more sources
Cryptogenic and secondary organizing pneumonia: Clinical presentation, radiological and laboratory findings, treatment, and prognosis in 56 cases [PDF]
, 2018 OBJECTIVES: Organizing pneumonia is an important disease that is associated with non-specific clinical findings and radiographic appearance. Our aim was to examine the clinical and radiological features, laboratory findings, diagnostic approach, and ...
Akyürek, Nalan +6 more
core +2 more sources